Acne erupted on her cheeks, nose, chin and forehead
In STEP 4 (Rubino et al., JAMA 2021), all patients from week 0 to week 20 reached the full 2.4 mg weekly dose and lost an average of 10.6% of body weight in those 20 weeks
Any discrepancies identified during extraction or verification were resolved through consensus among the reviewers
Blood sugar control FDA-approved as Mounjaro for type 2 diabetes, studied for its glucose-dependent insulin release and glucagon suppression
Individual responses differ
FDA Safety Announcement: Saxenda FDA Safety Label Change and Revised Drug LabelThe revised drug label contains a complete list of FDA-approved indications, side effects, warnings, and more